Company / FCF Margin
Regenerative Medical Technology Group Inc. FCF Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-25.7%
FY2025
5-year range
-85.8% / 15.5%
FY2021-FY2025
Trend
-265.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -266% YoY in FY2025, a notable deviation from the 6-year average annual change of -22%.
Based on SEC 10-K filings.
-25.7% in FY2025 with a 5-year CAGR of +741.8%.
Improved from -33.4% to -25.7% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +60.1pp
- 5-Year Change
- +741.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 265.9% year-over-year.
- Peak fcf margin was recorded in FY2024.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -25.7% | -265.9% |
| FY2024 | 15.5% | +146.3% |
| FY2023 | -33.4% | +61.1% |
| FY2022 | -85.8% | - |
| FY2021 | - | - |
| FY2020 | -767.5% | +50.0% |
| FY2019 | -1535.8% | -209.6% |
| FY2018 | -496.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026